SCHEMBL4552648

SCHEMBL4552648

CC1=C(/C=C/c2cccc(CCCCN)c2)C(C)(C)CCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.40
RXRA P19793 2/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
HMGCR P04035 1/20 0.39
RARA P10276 3/20 0.37
RARB P10826 3/20 0.37
RARG P13631 3/20 0.37
HAO1 Q9UJM8 1/20 0.36
PLA2G2A P14555 1/20 0.35
PLA2G4A P47712 1/20 0.35
ALDH1A1 P00352 3/20 0.35
LMNA P02545 1/20 0.35
PTGS1 P23219 1/20 0.35
DRD3 P35462 1/20 0.35
SLCO1B3 Q9NPD5 1/20 0.35
SLCO1B1 Q9Y6L6 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
MAOA P21397 1/20 0.34
MAPT P10636 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4552651 1.00 CYP1A2 (0.40) CYP1A2RXRARXRBRXRGHMGCR
SCHEMBL4172588 0.97 CYP1A2 (0.41) CYP1A2RXRARXRBRXRGHMGCR
SCHEMBL4172590 0.97 CYP1A2 (0.41) CYP1A2RXRARXRBRXRGHMGCR
SCHEMBL4176067 0.92 TAAR1 (0.43) CYP1A2RXRARXRBRXRGRARA
SCHEMBL4176064 0.92 TAAR1 (0.43) CYP1A2RXRARXRBRXRGRARA
Oxalic Acid SCHEMBL4175839 0.91 CYP1A2 (0.47) CYP1A2RXRARXRBRXRGHMGCR
Oxalic Acid SCHEMBL4175842 0.91 CYP1A2 (0.47) CYP1A2RXRARXRBRXRGHMGCR
SCHEMBL4171195 0.87 CYP1A2 (0.45) CYP1A2RXRARXRBRXRGRARA
SCHEMBL4171193 0.87 CYP1A2 (0.45) CYP1A2RXRARXRBRXRGRARA
SCHEMBL4412235 0.86 CYP1A2 (0.44) CYP1A2RXRARXRBRXRGHMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2076124-A2 STYRENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS Acucela, Inc. (US) 2009-07-08 EP disclosed
WO-2008131368-A2 STYRENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ACUCELA INC. (US) 2008-10-30 WO disclosed